Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filings

Filing date Form Description Filing Group View
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

Registration Statements
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
CERTNAS

CERTNAS

Other
View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
View HTML
D
Other
View HTML